Lynx1 Capital Management LP

Holdings History for TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)

Symbol: TCRX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Voting Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 5.36M shares
Security Ownership: 10.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Lynx1 Capital Management LP ownership in TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share (TCRX)

2025-02-14 - Lynx1 Capital Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.36M shares of TScan Therapeutics, Inc. Voting Common Stock, $0.0001 par value per share (TCRX). This represents 10.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Lynx1 Capital Management LP	10.9%		$9.59M	5.36M			$1.79	13G/A	12/31/2024	14 Feb 2025 09:00:17

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	6.11%	+0.15%	$16.3M	5.36M	+132,747	+2.54%	$3.04	Q4 2024
9/30/2024	9.22%		$26M	5.22M			$4.98	Q3 2024
6/30/2024	11%		$30.6M	5.22M			$5.85	Q2 2024
3/31/2024	10.7%		$41.5M	5.22M			$7.94	Q1 2024
12/31/2023	12%		$30.5M	5.22M			$5.83	Q4 2023
9/30/2023	8.85%		$13.4M	5.22M			$2.56	Q3 2023
6/30/2023	8.56%	+8.56%	$13.1M	5.22M	+5,224,600	NEW	$2.50	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.